Zonia Noren

A New Option to Treat Intermediate Hepatocellular Carcinoma?

September 15, 2024

BARCELONA — Adding lenvatinib and pembrolizumab to transarterial chemoembolization (TACE) led to a significant improvement in progression-free survival in patients...

Zonia Noren

A New Option to Treat Intermediate Hepatocellular Carcinoma?

Oncologica to advance urine-based prostate cancer screening test

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

FDA Approves Benralizumab for EGPA Vasculitis Indication

Study finds early puberty linked to higher risk for HS

CGM Cuts Hospitalization in T2D, Even in Non-Insulin Treated

Summer COVID surge isn’t cause for alarm, experts say

Budget FY25: Pharmaceuticals sector needs a major boost with increased focus on R&D and innovation

Dental veneers: Everything you need to know

Cheeky diet soft drink getting you through the work day? Here’s what that may mean for your health

UK teenagers get two-thirds of their calories from ultra-processed foods—new study

Oncologica to advance urine-based prostate cancer screening test

Not just a normal part of aging: Dizziness in older adults is linked to higher risk of future falls

FDA Approves Benralizumab for EGPA Vasculitis Indication

Study finds early puberty linked to higher risk for HS

CGM Cuts Hospitalization in T2D, Even in Non-Insulin Treated

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories